Gap junction (GJ) channels facilitate cell -cell communication through the exchange of chemical and mechanical signals, ensuring proper tissue development and homeostasis. The complex, disease stage-dependent role of connexins in breast cancer progression has been extensively studied over the past two decades. In the early stages of breast cancer, substantial evidence supports the role of GJ channels, formed by connexins at the interfaces between neighbouring cells, as suppressors of cell migration and proliferation. These findings suggest that materials that reintroduce connexins into the tumour cell environment have the potential to inhibit cell migration. Here, we report that exposure of highly metastatic MDA-MB-231 breast tumour cells to connexin-rich biovesicle materials potently suppresses cell migration. Specifically, these biovesicles, which can form GJ interfaces with cells, were extracted from the plasma membrane of donor cells engineered to express a high concentration of functional connexin 43 channels. These connexin-rich membrane materials dramatically reduced cell migration in both a transwell migration assay and a scratch closure assay. Collectively, these results suggest that using membrane materials to reintroduce connexins into the tumour cell environment provides a novel approach for combating cell migration and invasion.
Introduction
Connexins are a family of protein channels involved in the formation of gap junctions (GJs) between neighbouring cells [1] . Through this network of channels, cells communicate with each other, exchanging small metabolites, secondary messengers, small interfering RNAs [2] , peptides and other small molecules [1] . The disruption of GJ networks resulting in the loss of these intercellular connections has been associated with multiple diseases, including cancer [3] [4] [5] . Although the role of connexins in cancer is complex and contextdependent [5] [6] [7] , with multiple and varied mechanistic pathways involved at different stages of the disease [8] , several pieces of evidence support the correlation between reduced gap junctional coupling among breast tumour cells and increased tumorigenesis, tumor cell migration and invasion in the early stages of breast cancer [6, [9] [10] [11] [12] . As one example, in the highly metastatic MDA-MB-231 breast cancer cell line, endogenous connexin 43 is not efficiently trafficked to the plasma membrane, resulting in a reduction of the concentration of GJs at the cell surface [9] . Interestingly, independent studies from several laboratories have shown that the overexpression of connexins in these cells reduces the ability of cells to migrate, invade surrounding tissue, and metastasize to distant sites [9, 13, 14] . These reports suggest that restoring the GJ network among tumour cells has the potential to suppress migration, invasion, and metastasis of breast cancer cells and possibly other tumorogenic cells, inspiring significant interest in GJs as novel therapeutic targets [15, 16] .
Towards using connexins to suppress cell migration and metastatsis, we have recently demonstrated that membrane vesicles that incorporate a high & 2017 The Author(s) Published by the Royal Society. All rights reserved.
concentration of connexin 43 proteins are capable of forming functional GJ interfaces with living cells [17] . To facilitate the incorporation of functional, properly oriented connexins into membrane materials, we extracted vesicles from the plasma membrane of donor cells engineered to express high levels of connexin 43. The process of extracting the cellular plasma membrane, which relies on cellular blebbing [18] , has previously provided membrane vesicles with functional protein content for both fundamental [19] and therapeutic [20] studies. Here, we demonstrate the potent ability of these connexin-rich membrane vesicles to suppress the migration of metastatic breast cancer cells. These data establish a novel, materials-based approach for suppressing cell migration and metastasis.
Characterization of gap junction vesicles and their interaction with breast cancer cells
GJ vesicles were extracted from the plasma membrane of HeLa donor cells overexpressing connexin 43-YFP proteins (figure 1a).
The unprocessed GJ vesicles ranged in diameter from 3 to 14 mm, with an average diameter of 7.5 mm (figure 1b). Approximately 63% of the GJ vesicles contained connexin 43-YFP at levels detectable by fluorescence imaging, similar to previously reported data [17] . Using the same blebbing process, biovesicles of similar size and morphology were obtained from MDA-MB-231 and HeLa cells. The level of connexin 43 expression and the degree of connexin 43 localization to cell-cell junctions were assessed for all cell lines based on a combination of immunostained confocal fluorescence imaging and flow cytometry (electronic supplementary material, figure S1 ), western blot (electronic supplementary material, figure S2 ) and the scratch loading assay of connexin function (electronic supplementary material, figure S3 ). As expected, HeLa cells overexpressing connexin 43 present increased levels of connexin 43 expression in comparison to wild-type HeLa and MDA-MB-231 cells. These findings are consistent with reports of low connexin expression by HeLa and MDA-MB-231 cells [9, 21] . GJ vesicles were used either as obtained from cells (unprocessed) or after extrusion through a 1 mm polycarbonate membrane, to obtain a more uniform vesicle size distribution in the submicrometre size range (figure 1c). To more easily visualize the extruded biovesicles, we stained the donor cells with Texas Red DHPE immediately before blebbing.
To verify the biological activity of the connexin proteins embedded in the biovesicles, we used the innate calcium-induced gating of the connexon channels as the basis of a functional assay [22, 23] . Specifically, calcium induces closure of connexon channels, while the absence of calcium causes a conformational change in the connexin proteins that opens the channel. Donor cells were treated with calcein red-orange acetomethoxy dye (CRO AM). As the dye can freely diffuse through the cell membrane, the cell cytoplasm was loaded with the dye, resulting in dye encapsulation within biovesicles. However, when in the cell cytoplasm the acetomethoxy group of the CRO AM dye is hydrolysed, making the dye membrane impermeable. Therefore, the CRO dye inside the biovesicle can diffuse out only through opened membrane channels. Upon calcium depletion, the CRO dye encapsulated within the GJ biovesicles was released (figure 1d,f ). By contrast, the biovesicles extracted from MDA-MB-231 cells, as well as biovesicles extracted from an additional tumorogenic cell line with low connexin 43 expression, A549 cells [24] , released very low levels of encapsulated dye upon calcium treatment (figure 1e,f ). These results suggest the presence of functional connexons in the membranes of GJ biovesicles.
Next, we evaluated the interaction between GJ vesicles and highly metastatic MDA-MB-231 breast cancer cells [25] . Notably, although MDA-MB-231 cells express reduced levels of connexin 43, immunostained imaging and flow cytometry experiments confirmed that some connexin 43 proteins remain present on the cellular plasma membrane surface and are localized to cell -cell junctions (electronic supplementary material, figure S1 ), suggesting that MDA-MB-231 cells may be able to interact functionally with GJ vesicles. Imaging of the MDA-MB-231 cells (electronic supplementary material, figure S4 ) and HeLa cells expressing connexin 43-YFP (figure 1g) after 4 h of incubation with the extruded Texas Red-labelled GJ vesicles revealed accumulation of GJ vesicles at the cell membrane. The impact of connexin 43 expression on the interaction between biovesicles and recipient cells was measured using flow cytometry to quantify the fluorescence of MDA-MB-231 cells exposed to either Texas Red-labelled GJ vesicles or Texas Red-labelled biovesicles derived from wild-type HeLa cells. As shown in figure 1h,i, treating MDA-MB-231 cells with GJ vesicles resulted in a significantly higher average florescence intensity per cell compared to the untreated control cells and cells treated with HeLa cell-derived biovesicles. These results demonstrate that expression of connexin 43 proteins on the biovesicle surface enhances adhesion to MDA-MB-231 cells, suggesting that the limited concentration of connexin 43 proteins on the surfaces of these cells (electronic supplementary material, figure S1 ) is sufficient for functional interaction with GJ vesicles. Additionally, an MTT proliferation assay indicated that intact and extruded GJ vesicles dosed at 5 and 10 GJ vesicles per cell, counted prior to extrusion, did not negatively impact the proliferation of MDA-MB-231 cells (figure 1j ). The migration studies presented below were performed at ratios that did not exceed these levels.
Gap junction vesicles inhibit breast cancer cell migration
The ability of GJ vesicles to influence migration of metastatic MDA-MB-231 cells was assessed with both a transwell migration assay and a scratch closure assay. Cells were starved for 24 h and then seeded in serum-free medium on a permeable Transwell TM membrane, pre-coated with basement membrane extract (BME), mainly composed of laminin and collagen IV. Cells were treated with extruded GJ vesicles at increasing vesicle to cell ratios. Medium with serum was placed in the lower compartment as a chemoattractant. After 24 h, cells that invaded the BME and migrated through the membrane were stained with crystal violet and counted (figure 2a). Exposure of cells to GJ vesicles led to a concentration-dependent reduction in the migration of MDA-MB-231 cells ( figure 2b,c) . Specifically, for low GJ vesicle to cell ratios, 0.025 : 1 and 0.05 : 1, the impact on migration was minimal, but for ratios above 0.1 : 1, the decrease in migration in comparison to untreated cells became statistically significant ( p , 0.05), with a 50% reduction in cell migration for the ratio 0.2 : 1. The decrease in migration was greater than 90% for ratios exceeding 0.4 : 1. The impact of GJ vesicles on MDA-MB-231 cell migration was compared to the impact of biovesicles extracted from wild-type HeLa cells, which possess reduced levels of connexin 43. Exposing cells to biovesicles extracted from wild-type HeLa cells at a concentration of five biovesicles to one recipient cell reduced migration significantly (figure 2b). However, at biovesicle to cell ratios of both 0.4 : 1 and 5 : 1, biovesicles extracted from wild-type HeLa cells elicited a significantly smaller effect ( p , 0.01) on cell migration in comparison to equal concentrations of GJ vesicles (figure 2b). Specifically, while exposure to GJ vesicles in a ratio of 0.4 : 1 reduced migration by approximately 10-fold, exposure to biovesicles from wild-type HeLa cells in the same ratio reduced migration negligibly in comparison to untreated cells (figure 2b). As the primary difference between GJ vesicles and biovesicles extracted from wildtype HeLa cells is the overexpression of connexin 43 in the donor cells, these results strongly suggest that the impact of GJ vesicles on cell migration is connexin 43-dependent.
The decrease in migration upon treatment with GJ vesicles was further verified with a scratch closure assay ( figure 2d,e) . In this assay, we measured the impact of GJ vesicles and control biovesicles on the closure of a scratch in a confluent cell monolayer [26] . While the transwell migration assay measures the ability of cells to invade through a BME and migrate towards a chemoattractant, the scratch assay measures the ability of a monolayer to close by directed migration and cell spreading. To perform the assay, a scratch with a width of a few hundred micrometres was created through a confluent monolayer of MDA-MB-231 cells (figure 2d). The width of the scratch, normalized to the original width, was recorded at fixed time points. Untreated cells closed the scratch completely within 20 h (figure 2d,e and electronic supplementary material, figure S5 ). By contrast, for MDA-MB-231 cells treated with either unprocessed or extruded GJ vesicles at a ratio of 10 : 1 GJ vesicles per cell, migration was dramatically reduced (figure 2d,e and electronic supplementary material, figure S5 ). Consistent with the results of the transwell migration assay, extruded biovesicles from wild-type HeLa cells elicited a much smaller effect in comparison to the extruded GJ vesicles (figure 2d,e). Specifically, exposure to extruded HeLa biovesicles resulted in the scratch remaining on average 48% open after 7.5 h, while full closure of the scratch occurred within 20 h. These values were similar to scratch closure by untreated control cells, for which scratches remained on average 39% open after 7.5 h and complete closure was recorded at 20 h. By contrast, exposure to either unprocessed or extruded GJ vesicles resulted in no significant closure of the scratch, even after 20 h of exposure. Notably, cells treated with GJ vesicles appear slightly more rounded in comparison to untreated cells, suggesting they adhere less strongly to the well substrate (electronic supplementary material, figure S6 ). In line with this observation, negative feedback between cell-matrix adhesion and cell-cell interaction is well established, and reduced cell-matrix interactions are associated with reduced traction and cell motility [27] . Therefore, reinforcement of cell-cell interactions by GJ vesicles may weaken cell-matrix adhesion, leading to the observed reduction in cell migration. Importantly, biovesicles had no measurable impact on cell viability (figure 1j ), indicating that the observed changes in cell shape are not associated with a loss of viability.
In conclusion, our results demonstrate that connexin vesicle materials are capable of potently suppressing the migration of metastatic tumour cells. Collectively, the data support the hypothesis that GJ vesicles reintroduce functional rsif.royalsocietypublishing.org J. R. Soc. Interface 14: 20170313 connexin 43 proteins into the tumour cell environment, leading to a potent suppression of cell migration. The impact of these materials on cell migration can be broadly understood in the context of the ability of connexin expression to reduce the migration and invasion of metastatic breast cancer cells [3, 9, 13, 14] . Owing to the high mortality associated with metastatic cancer, there is an urgent need for the development of therapeutic approaches specifically aimed at reducing metastasis. However, drugs that prevent metastasis are limited and inefficient at present [28] , and few if any materials-based approaches currently exist for combating cell migration. Although the definite mechanism of action has not yet been elucidated and several pathways could be involved, including GJ [11] or non-GJ-mediated processes [8, 29] , the ability of GJ vesicles to dramatically reduce breast cancer cell migration could suggest a promising new approach for anti-metastatic therapy. The results presented here provide a basis for future studies addressing the mechanism of action of GJ vesicles and the potential effect of biovesicles incorporating other connexin proteins or a combination of connexins. In addition, preclinical testing and formulation development based on autologous donor cells will constitute the natural progression of the work towards clinical application. These efforts will benefit from the ongoing studies towards clinical translation of other biovesicle-based drug delivery systems including exosomes, viral particles [30] and extracellular vesicles [31, 32] .
